This might make measuring PTH and its standardization more difficult in CKD patients due to the high variability of the oxPTH percentage from patient to patient and in non-CKD patients due to oxPTH levels that are below the lower detection limits of conventional analytical methods. The gene discussed is PTH; the disease is chronic kidney disease.